Filing Details

Accession Number:
0001415889-24-017507
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-18 20:15:03
Reporting Period:
2024-06-15
Accepted Time:
2024-06-18 20:15:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1370053 Anaptysbio Inc ANAB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187333 Hollings Renton C/O Anaptysbio, Inc.
10770 Wateridge Circle, Suite 210
San Diego CA 92121
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-15 3,900 $0.00 3,900 No 4 M Direct
Common Stock Disposition 2024-06-18 1,950 $23.16 1,950 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2024-06-15 3,900 $0.00 3,900 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  2. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024
  3. The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.